Zions Bancorporation’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $68.9K | Hold |
171
| – | – | ﹤0.01% | 398 |
|
|
2024
Q3 | $79.5K | Sell |
171
-45
| -21% | -$21.6K | 0.01% | 396 |
|
|
2024
Q2 | $101K | Sell |
216
-83
| -28% | -$36K | 0.01% | 381 |
|
|
2024
Q1 | $125K | Sell |
299
-707
| -70% | -$299K | 0.01% | 349 |
|
|
2023
Q4 | $409K | Sell |
1,006
-143
| -12% | -$52.8K | 0.03% | 264 |
|
|
2023
Q3 | $400K | Sell |
1,149
-24
| -2% | -$8.39K | 0.04% | 256 |
|
|
2023
Q2 | $413K | Sell |
1,173
-11
| -0.9% | -$3.71K | 0.03% | 261 |
|
|
2023
Q1 | $373K | Buy |
1,184
+368
| +45% | +$110K | 0.03% | 262 |
|
|
2022
Q4 | $236K | Buy |
816
+65
| +9% | +$19.8K | 0.02% | 303 |
|
|
2022
Q3 | $217K | Sell |
751
-2
| -0.3% | -$575 | 0.02% | 299 |
|
|
2022
Q2 | $212K | Buy |
753
+37
| +5% | +$9.9K | 0.02% | 308 |
|
|
2022
Q1 | $187K | Buy |
716
+420
| +142% | +$99.7K | 0.02% | 329 |
|
|
2021
Q4 | $65K | Sell |
296
-55
| -16% | -$10.7K | 0.01% | 429 |
|
|
2021
Q3 | $64K | Sell |
351
-153
| -30% | -$29.9K | 0.01% | 424 |
|
|
2021
Q2 | $102K | Buy |
504
+178
| +55% | +$37.2K | 0.01% | 352 |
|
|
2021
Q1 | $70K | Sell |
326
-22
| -6% | -$4.83K | 0.01% | 377 |
|
|
2020
Q4 | $82K | Sell |
348
-10
| -3% | -$2.29K | 0.01% | 335 |
|
|
2020
Q3 | $97K | Buy |
358
+61
| +21% | +$16.8K | 0.01% | 293 |
|
|
2020
Q2 | $86K | Sell |
297
-15
| -5% | -$4.07K | 0.01% | 289 |
|
|
2020
Q1 | $74K | Sell |
312
-77
| -20% | -$17.7K | 0.01% | 284 |
|
|
2019
Q4 | $85K | Sell |
389
-18
| -4% | -$3.64K | 0.01% | 335 |
|
|
2019
Q3 | $69K | Hold |
407
| – | – | 0.01% | 374 |
|
|
2019
Q2 | $75K | Sell |
407
-45
| -10% | -$7.87K | 0.01% | 338 |
|
|
2019
Q1 | $83K | Sell |
452
-4
| -0.9% | -$739 | 0.01% | 332 |
|
|
2018
Q4 | $76K | Sell |
456
-7
| -2% | -$1.21K | 0.06% | 140 |
|
|
2018
Q3 | $89K | Buy |
463
+24
| +5% | +$4.27K | 0.02% | 254 |
|
|
2018
Q2 | $75K | Buy |
+439
| New | +$68K | 0.05% | 140 |
|
|
2018
Q1 | – | Sell |
-446
| Closed | -$67K | – | 701 |
|
|
2017
Q4 | $67K | Buy |
446
+22
| +5% | +$3.26K | 0.01% | 307 |
|
|
2017
Q3 | $64K | Buy |
424
+367
| +644% | +$55.2K | 0.01% | 517 |
|
|
2017
Q2 | $7K | Sell |
57
-69
| -55% | -$8.31K | ﹤0.01% | 395 |
|
|
2017
Q1 | $15K | Sell |
126
-148
| -54% | -$13K | ﹤0.01% | 318 |
|
|
2016
Q4 | $20K | Buy |
274
+42
| +18% | +$3.42K | ﹤0.01% | 383 |
|
|
2016
Q3 | $17K | Buy |
232
+40
| +21% | +$3.78K | ﹤0.01% | 407 |
|
|
2016
Q2 | $17K | Buy |
192
+12
| +7% | +$1.04K | ﹤0.01% | 367 |
|
|
2016
Q1 | $16K | Buy |
180
+34
| +23% | +$3.08K | ﹤0.01% | 440 |
|
|
2015
Q4 | $13K | Sell |
146
-22
| -13% | -$2.66K | ﹤0.01% | 445 |
|
|
2015
Q3 | $20K | Buy |
+168
| New | +$21.6K | ﹤0.01% | 358 |
|
|
2015
Q2 | – | Sell |
-163
| Closed | -$19K | – | 727 |
|
|
2015
Q1 | $19K | Buy |
+163
| New | +$19.5K | ﹤0.01% | 393 |
|
Other funds holding VRTX
Zions Bancorporation's VRTX Position: Q4 2024 in Review
Zions Bancorporation held its Vertex Pharmaceuticals (VRTX) position steady in Q4 2024 at 171 shares worth $68.9K. The position accounts for ﹤0.01% of the portfolio, ranked #398.
Zions Bancorporation first reported a position in VRTX in Q1 2015 and has held it in 38 quarters since. The position peaked at $413K in Q2 2023. 1,558 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.
- Zions Bancorporation held 171 shares of Vertex Pharmaceuticals worth $68.9K as of Q4 2024.
- Zions Bancorporation left its Vertex Pharmaceuticals share count unchanged in Q4 2024.
- Vertex Pharmaceuticals made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #398 holding.
- Zions Bancorporation first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 38 quarters since.
- Zions Bancorporation's Vertex Pharmaceuticals position peaked at $413K in Q2 2023.
- 1,558 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.